|
Native Antigen Inc
zikv ns1 uganda strain Zikv Ns1 Uganda Strain, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Zika+Virus+NS1+Protein+(Uganda+Strain)/pmc08266044-151-14-18 Average 94 stars, based on 1 article reviews
zikv ns1 uganda strain - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Boster Bio
pcdna3 1 ns1 pr8 Pcdna3 1 Ns1 Pr8, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Human+PTPN11+Recombinant+Protein/pm20826615-192-10-31 Average 91 stars, based on 1 article reviews
pcdna3 1 ns1 pr8 - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
Danaher Inc
pcna ![]() Pcna, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Recombinant+Dengue+virus+1+NS1+protein/pmc10067355-61-21-19 Average 99 stars, based on 1 article reviews
pcna - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mouse monoclonal anti ns1 ![]() Mouse Monoclonal Anti Ns1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Influenza+A+ns1+Antibody/pmc11301072-2-0-4 Average 94 stars, based on 1 article reviews
mouse monoclonal anti ns1 - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Meridian Life Science
purified, recombinant zikv ns1 ![]() Purified, Recombinant Zikv Ns1, supplied by Meridian Life Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/recombinant+zikv+e+protein/pm29099873-164-7-12 Average 90 stars, based on 1 article reviews
purified, recombinant zikv ns1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Sino Biological
recombinant zikv proteins ![]() Recombinant Zikv Proteins, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Recombinant+Protein+A/pmc11256112-567-2-7 Average 96 stars, based on 1 article reviews
recombinant zikv proteins - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
yellow fever virus ns1 protein ![]() Yellow Fever Virus Ns1 Protein, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Yellow+Fever+Virus+NS1+Protein/custom%40yfv-ns1%4035810191 Average 93 stars, based on 1 article reviews
yellow fever virus ns1 protein - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
recombinant ns1 protein ![]() Recombinant Ns1 Protein, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Tick-Borne+Encephalitis+Virus+(European)NS1+Protein/pmc07098735-121-0-6 Average 94 stars, based on 1 article reviews
recombinant ns1 protein - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Danaher Inc
recombinant dengue virus ns1 glycoprotein ![]() Recombinant Dengue Virus Ns1 Glycoprotein, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Recombinant+Dengue+Virus+2+NS1+glycoprotein/pm27665517-81-12-28 Average 99 stars, based on 1 article reviews
recombinant dengue virus ns1 glycoprotein - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
Biosynth Carbosynth
recombinant ns1 protein ![]() Recombinant Ns1 Protein, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Zika+virus+NS1+protein/pm34013833-72-9-12 Average 91 stars, based on 1 article reviews
recombinant ns1 protein - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
Bio-Rad
recombinant dengue virus type 1 ns1 antigen pip047a ![]() Recombinant Dengue Virus Type 1 Ns1 Antigen Pip047a, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/Antigen+(Chicken+%CE%B3-Globulin)/pm34496209__nl1c01609_si_001-40-10-21 Average 96 stars, based on 1 article reviews
recombinant dengue virus type 1 ns1 antigen pip047a - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
BioFront Technologies Inc
recombinant zika ns1 antigen bf-ns1-6309 ![]() Recombinant Zika Ns1 Antigen Bf Ns1 6309, supplied by BioFront Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+tbev+ns1+proteins/anti+zikv+ns1/pmc07168132-67-15-20 Average 90 stars, based on 1 article reviews
recombinant zika ns1 antigen bf-ns1-6309 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Thoracic Cancer
Article Title: Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR ‐6838‐5p
doi: 10.1111/1759-7714.14820
Figure Lengend Snippet: Knockdown of circ_0001667 inhibited proliferation and angiogenesis in breast cancer cells. MDA‐MB‐231 and BT549 cells were transfected with si‐NC or si‐circ_0001667. (a) qRT‐PCR assay for silencing efficiency of si‐circ_0001667. (b‐d) CCK8 and EdU assays to detect proliferation of breast cancer cells. Scale bar: 50 μm. (e and f) Flow cytometry was used to determine the cycle distribution of breast cancer cells. (g) Colony formation assay was used to assess the colony formation ability. (h) Western blot to measure the protein levels of PCNA and Ki67. (i) Tube formation assay was used to analyze angiogenesis of breast cancer cells. (j) Western blot showing the expression levels of VEGFA and FGF2 in breast cancer cells. * p < 0.05.
Article Snippet: The separated proteins were electrotransferred to PVDF membrane (Beyotime), closed with 10% skimmed milk, and incubated with primary antibodies (
Techniques: Knockdown, Transfection, Quantitative RT-PCR, Flow Cytometry, Colony Assay, Western Blot, Tube Formation Assay, Expressing
Journal: Thoracic Cancer
Article Title: Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR ‐6838‐5p
doi: 10.1111/1759-7714.14820
Figure Lengend Snippet: Downregulation of miR‐6838‐5p attenuated the effect of circ_0001667 knockdown on cell proliferation and angiogenesis. (a) qRT‐PCR analysis of miR‐6838‐5p levels in cells transfect with anti‐miR‐6838‐5p or anti‐miR‐NC. (b‐j) MDA‐MB‐231 and BT549 cells were transfected with si‐NC, si‐circ_0001667, si‐circ_0001667 + anti‐miR‐NC or si‐circ_0001667 + anti‐miR‐6838‐5p. (b‐d) CCK‐8 and EdU assays detected cell proliferation. (e and f) Flow cytometry determined cell cycle distribution. (g) The colony formation assay assessed the colony formation ability. (h) Western blot measured the protein levels of PCNA and Ki67. (i) Tube formation test analyzed angiogenesis. (j) Western blot showed the expression levels of VEGFA and FGF2. * p < 0.05.
Article Snippet: The separated proteins were electrotransferred to PVDF membrane (Beyotime), closed with 10% skimmed milk, and incubated with primary antibodies (
Techniques: Knockdown, Quantitative RT-PCR, Transfection, CCK-8 Assay, Flow Cytometry, Colony Assay, Western Blot, Expressing
Journal: Thoracic Cancer
Article Title: Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR ‐6838‐5p
doi: 10.1111/1759-7714.14820
Figure Lengend Snippet: Overexpression of CXCL10 reversed the effects of miR‐6838‐5p overexpression on cell proliferation and angiogenesis. (a and b) Validation of CXCL10 overexpression by qRT‐PCR and western blot. (c–k) MDA‐MB‐231 and BT549 cells were transfected with miR‐NC, miR‐6838‐5p, miR‐6838‐5p + pcDNA or miR‐6838‐5p + CXCL10. (c–h) CCK8 assay, EdU assay, flow cytometry and colony formation assay detected cell proliferation. (i) Western blot analysis for PCNA and Ki67 levels. (j) Tube formation test detected angiogenesis. (k) Western blotting quantified the levels of VEGFA and FGF2. * p < 0.05.
Article Snippet: The separated proteins were electrotransferred to PVDF membrane (Beyotime), closed with 10% skimmed milk, and incubated with primary antibodies (
Techniques: Over Expression, Biomarker Discovery, Quantitative RT-PCR, Western Blot, Transfection, CCK-8 Assay, EdU Assay, Flow Cytometry, Colony Assay
Journal: iScience
Article Title: Influenza A virus infection activates STAT3 to enhance SREBP2 expression, cholesterol biosynthesis, and virus replication
doi: 10.1016/j.isci.2024.110424
Figure Lengend Snippet:
Article Snippet:
Techniques: Virus, Recombinant, Staining, RNA Extraction, cDNA Synthesis, Transfection, Cloning, Cell Viability Assay, Software, CRISPR
Journal: Science translational medicine
Article Title: Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at one year postpartum
doi: 10.1126/scitranslmed.aaz4997
Figure Lengend Snippet: Shown is the study timeline for ZIKV infection of rhesus macaque dams, delivery of offspring, blood and cerebrospinal fluid sampling, MRI, reinfection of offspring with ZIKV at 13–15 months of age, and necropsy. M, mock-infected; E, early gestational infection; L, late gestational infection; D, dam; I, infant offspring. The first dam and infant pair from each cohort were euthanized at the time of delivery and their tissues were analyzed. The remainder of the infants were observed for the entirety of the study.
Article Snippet: The purified
Techniques: Infection, Sampling
Journal: Science translational medicine
Article Title: Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at one year postpartum
doi: 10.1126/scitranslmed.aaz4997
Figure Lengend Snippet: Serum and amniotic fluid samples were obtained prenatally and postnatally at different time points after infection of macaque dams with ZIKV. Samples were assayed for ZIKV RNA (Log10 GE/ml) by qPCR; negative ZIKV RNA readings are not shown. Total ZIKV-specific neutralizing antibodies in serum are represented by the dilution that achieved a 50% reduction in viral plaques (PRNT50 test). All PRNT50 positive and negative readings are shown. The vertical dotted line indicates time of birth for offspring. All ZIKV-infected dam-infant pairs are shown. All ZIKV RNA and PRNT50 measurements from the mock-infected dam-infant pairs were below the limit of detection.
Article Snippet: The purified
Techniques: Infection
Journal: Science translational medicine
Article Title: Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at one year postpartum
doi: 10.1126/scitranslmed.aaz4997
Figure Lengend Snippet: Shown are the kinetics of IgM, IgA, and IgG antibodies against ZIKV envelope (E) protein and NS1 protein in blood samples from ZIKV-infected dams (A) and their infant offspring (B). Antibody binding to ZIKV protein-coated sensors was detected by surface plasmon resonance and is expressed as maximum relative units (Max RU). Max RU was calculated by multiplying the observed RU signal by dilution factors. The dashed line indicates the lower limit of detection for the assay. E, early gestational infection; L, late gestational infection; D, dam; I, infant offspring.
Article Snippet: The purified
Techniques: Infection, Binding Assay, SPR Assay
Journal: Science translational medicine
Article Title: Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at one year postpartum
doi: 10.1126/scitranslmed.aaz4997
Figure Lengend Snippet: Two cohorts of animals were used in this study: the first comprised offspring born to dams that were not infected with ZIKV during pregnancy (15-month-old M2I and two additional two-year-old animals, C1 and C2), and the second cohort comprised the four 13–15-month-old offspring (E2I, E3I, L2I, L3I) born to dams that were infected with ZIKV while pregnant. All seven macaques were inoculated with the same strain and dose of ZIKV used for the primary infection (green triangle). Blood samples were taken at 1, 2, 3, 4, 5, 7, 10 and 12 days after inoculation (blue triangles). Cerebrospinal fluid was collected on days −14 (2 weeks before reinfection), 3 and 7 days after reinfection and at necropsy (blue triangles). Necropsies were performed 14–16 days after ZIKV reinfection. M, a macaque infant born to a dam mock-infected while pregnant; E, macaque infants born to dams infected with ZIKV during early gestation; L, macaque infants born to dams infected with ZIKV during late gestation; I, infant offspring.
Article Snippet: The purified
Techniques: Infection
Journal: Science translational medicine
Article Title: Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at one year postpartum
doi: 10.1126/scitranslmed.aaz4997
Figure Lengend Snippet: (A) ZIKV RNA (Log10 GE/ml) was quantified by qPCR in serum and cerebrospinal fluid (CSF) of M2I, C1 and C2 macaques (cohort 1, no prior ZIKV exposure), and E2I, E3I, L2I, L3I (cohort 2, 13–15-month-old offspring born to dams infected with ZIKV while pregnant). Results for all serum samples are shown. Only positive CSF measurements are indicated. The dotted line marks the limit of detection of the assay. (B) Shown are the amounts of total ZIKV-specific neutralizing antibodies in blood samples from the seven macaques represented by the dilution that achieved a 50% reduction in viral plaques (PRNT50 test). All PRNT50 data are shown. (C) Quantification by droplet digital PCR of ZIKV RNA in lymphoid, pulmonary, digestive, genitourinary and nervous system tissues from the two cohorts is presented. (D) Shown are ZIKV-specific T cell memory responses in blood samples from the seven macaques as well as a single dam infected during early pregnancy (E2D) measured by flow cytometry. Infant samples (E2I, E3I, L2I, L3I) were collected 30 days before the reinfection study; the dam sample was collected 23 days after inoculation with ZIKV during pregnancy. Data are presented as the percentage of cytokine-positive T cells after stimulation of PBMCs with ZIKV envelope and NS1 peptides (with subtraction of baseline, which is the percentage of the same cells producing cytokines without stimulation). Statistically significant differences between the peptide stimulated (N=3 technical replicates for each cell/cytokine combination) and unstimulated groups (N=3 technical replicates) were determined by Student’s t test (*p<0.05, **p<0.01, ***p<0.001). Data shown are mean +/− SEM. (E) Shown is a representative thoracic spinal cord section from infant E3I stained with hematoxylin and eosin showing mineralized lesions after ZIKV reinfection. Wallerian degeneration associated with digestion chambers in the cytoplasm of Schwann cells is indicated by black arrows. (F) Shown is a representative normal thoracic spinal cord section from infant M2I stained with hematoxylin and eosin. Scale bar is 20 μm.
Article Snippet: The purified
Techniques: Infection, Digital PCR, Flow Cytometry, Staining
Journal: Biosensors & bioelectronics
Article Title: The capacitive sensing of NS1 Flavivirus biomarker.
doi: 10.1016/j.bios.2016.08.097
Figure Lengend Snippet: Fig. 2. ECS-ES approach for NS1 protein detection in PBS using the anti-NS1 functionalized electrode. (a) Example of Nyquist capacitive plots (C′′ is the imaginary and C′ is the real part of capacitance) recorded as a function of different concentrations of NS1 in PBS. Cr was measured by the projection of the semicircle diameter in the axis C′, corresponding to the frequency value where C′′ is minimized (at low frequencies) as shown in the inset. (b) Calibration curve using logarithm of different concentrations of NS1 in PBS (R2∼0.996) wherein the RSD showed for each concentration (errors bars) represents three repetitions of the same functionalized electrode. Note that this analytical curve was obtained by plotting RR C %∆[1/ ] r =100×( C 1/ r NS ( 1)−C 1/ r blank ( ))/ C 1/ ) r blank ( ) , where C 1/ r blank , is the inverse of the capacitance of the biosensor after exposing its surface to PBS solution without a target. Subsequently the surface was evaluated against different concentrations of NS1 (plotted in logarithm).
Article Snippet: All reagents described in this work were purchased from SigmaAldrich, except the
Techniques: Concentration Assay
Journal: Biosensors & bioelectronics
Article Title: The capacitive sensing of NS1 Flavivirus biomarker.
doi: 10.1016/j.bios.2016.08.097
Figure Lengend Snippet: Fig. 3. EIS-ES assay for NS1 protein in PBS. (a) Nyquist impedimetric plots recorded at different concentrations of NS1; the applied potential was ∼0.22 V. Rct was calculated by fitting the data to the Randle-like equivalent circuit model as illustrated in the inset in (a). The red lines are the adjusted curves to the equivalent circuit model. (b) Analytical calibration curve (R2∼0.990) using RR% against logarithm of NS1 at different concentrations with RSD (%) represented by error bars. Results extracted and adapted with permission from Cecchetto et al. (2015).
Article Snippet: All reagents described in this work were purchased from SigmaAldrich, except the
Techniques:
Journal: Biosensors & bioelectronics
Article Title: The capacitive sensing of NS1 Flavivirus biomarker.
doi: 10.1016/j.bios.2016.08.097
Figure Lengend Snippet: Fig. 4. Response of anti-NS1 interface in the presence of a nonspecific protein (Fetuin). a) Inverse of the capacitive response was typically less than 5% of C ∆(1/ ) r , in contrast to a variation of 43% of C ∆(1/ ) r for the specific response. b) Impedimetric response was typically less than 6% of Rct blockage, in contrast to a variation of 41% of Rct blockage for the specific response. Figure (b) reproduced with permission from Cecchetto et al. (2015).
Article Snippet: All reagents described in this work were purchased from SigmaAldrich, except the
Techniques:
Journal: Biosensors & bioelectronics
Article Title: The capacitive sensing of NS1 Flavivirus biomarker.
doi: 10.1016/j.bios.2016.08.097
Figure Lengend Snippet: Fig. 5. Detection of NS1 protein in neat serum by anti-NS1 functionalized electrode using ECS and EIS sensorial approaches. (a) Calibration curve using C 1/ r (ECS-ES) as signal transducer (R2 of 0.98) as a function of logarithm of NS1 at different concentrations, where RR C %∆[1/ ] r =100×( C 1/ r NS ( 1)−C 1/ r blank ( ))/ C 1/ ) r blank ( ) . The error bars indicate the standard deviation of triplicate measurements. (b) Calibration curve using Rct (EIS-ES) as signal transducer (R2 of 0.98 as a function of logarithm of NS1 at different concentrations Figure “b” adapted with permission from Cecchetto et al. (2015).
Article Snippet: All reagents described in this work were purchased from SigmaAldrich, except the
Techniques: Standard Deviation
Journal: Emerging microbes & infections
Article Title: Extracellular acidosis enhances Zika virus infection both in human cells and ex-vivo tissue cultures from female reproductive tract.
doi: 10.1080/22221751.2021.1932606
Figure Lengend Snippet: Figure 2. Acidosis enhances ZIKV infection in cells derived from the female reproductive tract and other target cells. Cells were incubated with ZIKV (A1C1-V2) at different pH values for 1 h at 37°C. Then, cells were washed and infection was assessed 72 h later. Infection of genital tract-derived cells VK2/E6E7 (A), Ect1/E6E7 (B), and End1/E6E7 (C) was quantified by measuring the extra- cellular concentration of NS-1 by Luminex. Infection of human endometrial fibroblasts (T-HESC) was quantified by qPCR (D). Infec- tion of monocyte-derived macrophages (MDM) was quantified by measuring the extracellular concentration of NS-1 by Luminex (E). Primary culture-derived human astrocytes (NHA) infection was measured by qPCR (F). Human ectocervical (G) and endocervical (H) tissue cultures were dissected into 2 mm [3] pieces and infected with ZIKV (VR-1844 moi 0.1) either at pH 7.3 or 6.2 for 1 h at 37°C. The viral production was evaluated at days 3, 6, 10, 13, 17, and 21 by measuring ZIKV NS1 in the culture supernatant. Results in A, B, C, D, and F represent data of two independent experiments. Data in E comprises the results of four different donors. Panels H and G were constructed with data of three independent experiments per explant type, and data were analysed using paired two-way ANOVA. Results are presented as mean ± SEM.
Article Snippet: The standard curve was obtained by serial dilution of
Techniques: Infection, Derivative Assay, Incubation, Concentration Assay, Luminex, Construct
Journal: Diagnostics
Article Title: Development of a Flow-Free Automated Colorimetric Detection Assay Integrated with Smartphone for Zika NS1
doi: 10.3390/diagnostics10010042
Figure Lengend Snippet: ( a ) Sandwich ELISA assay results using the recombinant Zika nonstructural protein 1 (NS1) antigen spiked on PBS buffer on 96-well plate as the Zika NS1 monoclonal antibody is used as a capture agent. Anti-Zika NS1 monoclonal antibody-HRP with a dilution factor of 1:1000 utilized to react with TMB calorigenic substrate to develop color. ( b ) M-ELISA assay on a 96-well plate showing spiking recombinant Zika NS1 on whole plasma. A 1:500 dilution factor of HRP-labeled anti-Zika NS1 was used and reacted with TMB to generate color. In both cases, color development was stopped by using H 2 SO 4 and absorbance was measured at 450 nm using a SpectraMax Gemini™ XPS/EM Microplate Reader (Molecular Devices, USA). Error bars are ±SD.
Article Snippet: It was rewashed three times carefully, followed by 90 min incubation of 100 μL of
Techniques: Sandwich ELISA, Recombinant, Enzyme-linked Immunosorbent Assay, Clinical Proteomics, Labeling